Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
ImmuCell Corporation (ICCC) had Return on Tangible Equity of -10.57% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$7.63M |
|
$-2.85M |
|
$4.72M |
|
$2.91M |
|
$7.68M |
|
$-0.06M |
|
$-2.79M |
|
$-2.85M |
|
$-2.85M |
|
$-2.85M |
|
$-2.85M |
|
$-2.85M |
|
$-2.85M |
|
$-0.06M |
|
$0.65M |
|
9.03M |
|
9.03M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$16.94M |
|
$21.07M |
|
$25.59M |
|
$42.53M |
|
$3.98M |
|
$7.49M |
|
$11.50M |
|
$15.48M |
|
$27.06M |
|
$26.96M |
|
$27.06M |
|
9.05M |
|
| Cash Flow Statement Financials | |
$2.48M |
|
$-1.21M |
|
$-1.21M |
|
$3.76M |
|
$3.81M |
|
$0.05M |
|
$0.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.26 |
|
-- |
|
-- |
|
0.22 |
|
0.34 |
|
38.16% |
|
-0.76% |
|
-0.76% |
|
-- |
|
-37.32% |
|
-37.36% |
|
$1.26M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.51 |
|
2.23 |
|
40.35 |
|
-10.53% |
|
|
Return on Tangible Equity |
-10.57% |
-6.70% |
|
-8.25% |
|
$2.99 |
|
$0.14 |
|
$0.27 |
|